|本期目录/Table of Contents|

[1]吴勤研,蓝晓红,吴波,等.基于生物信息技术分析人参皂苷防治乳腺癌的作用机制[J].医学研究与战创伤救治(原医学研究生学报),2022,24(3):282-288.[doi:10.3969/j.issn.1672-271X.2022.03.013]
 WU Qin-yan,LAN Xiao-hong,WU Bo,et al.Analysis of the mechanism of action of ginsenosides in preventing and treating breast cancer based on bioinformatics technology[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(3):282-288.[doi:10.3969/j.issn.1672-271X.2022.03.013]
点击复制

基于生物信息技术分析人参皂苷防治乳腺癌的作用机制()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第24卷
期数:
2022年3期
页码:
282-288
栏目:
药学研究
出版日期:
2022-06-30

文章信息/Info

Title:
Analysis of the mechanism of action of ginsenosides in preventing and treating breast cancer based on bioinformatics technology
作者:
吴勤研蓝晓红吴波魏玮李薛梅初晓玲高茗
作者单位:210002南京,东部战区总医院(原南京军区南京总医院)药剂科(吴勤研、蓝晓红、吴波、魏玮、李薛梅、初晓玲、高茗)
Author(s):
WU Qin-yan LAN Xiao-hong WU Bo WEI Wei LI Xue-mei CHU Xiao-ling GAO Ming
(Department of Pharmacy, General Hospital of Eastern Theater Command, PLA, Nanjing 210002, Jiangsu, China)
关键词:
生物信息技术人参皂苷乳腺癌作用机制
Keywords:
bioinformatics technology ginsenoside breast cancer mechanism
分类号:
R285.5
DOI:
10.3969/j.issn.1672-271X.2022.03.013
文献标志码:
A
摘要:
目的运用生物信息学技术探讨人参皂苷调控乳腺癌潜在的作用机制。方法从基因表达数据库(GEO)获取与乳腺癌相关的基因芯片GSE85871,并用GEO2R在线分析软件分析该芯片数据集,得到差异表达基因(DEGs)。分别运用SangerBox和GraphPad Prism 8图像处理软件对差异表达基因进行可视化处理。在SRING平台上构建蛋白互作(PPI)网络,利用Cytoscape 3.7软件分析该网络,获得核心基因。运用DAVID 6.8数据库对核心基因进行基因本体(GO)功能注释和京都基因百科全书(KEGG)通路富集。结果从芯片数据集中筛选出182个差异基因,其中上调基因有110个,下调基因有72个。核心基因涉及VEGFA,BMP4,SPARC,PLG,ITGB2,TEK, SERP,INA1,SERPINB5和IGFBP7。GO生物过程包括细胞黏附、蛋白质磷酸化的正调控、细胞间信号转导、胶质细胞迁移和血管生成的负调控等;KEGG信号通路包括细胞因子-细胞因子受体相互作用、阿米巴病、弓形体病和癌症中的微小RNA通路等。结论人参皂苷通过多靶点、多条信号通路的共同作用,发挥抗乳腺癌的药理作用。
Abstract:
ObjectiveBioinformatics technology were used to explore the potential mechanism of ginsenosides in the treatment of breastcancer.MethodsGene chips of GSE85871 related to breast cancer was obtained from the Gene Expression Database (GEO), and the dataset of chips were analyzed by GEO2R online analysis software to obtain differentially expressed genes (DEGs). DEGs were visualized by image processing software of SangerBox and GraphPad Prism8. Network of protein-protein interaction (PPI) was constructed on the SRING platform, and the network was analyzed by Cytoscape 3.7 software to obtain the core genes. Database of DAVID 6.8 was used to obtain Gene Ontology (GO) functional annotation and Kyoto Encyclopedia of Genes (KEGG) pathway enrichment of core genes.ResultsA total of 182 differential genes were screened from the microarray dataset, of which 110 were up-regulated and 72 were down-regulated. Core genes involved VEGFA, BMP4, SPARC, PLG, ITGB2, TEK, SERP, INA1, SERPINB5 and IGFBP7. GO biological processes included cell adhesion, positive regulation of protein phosphorylation, intercellular signal transduction, glial cell migration and negative regulation of angiogenesis. KEGG signaling pathway included cytokine-cytokine receptor interactions, amoeba disease, toxoplasmosis, and microRNA pathways in cancer.ConclusionGinsenoside plays an important role in anti-breast cancer through multi-target and multi-signal pathway.

参考文献/References:

[1]Siegel, Miller, Fuchs, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin,2021,71(1):7-33.
[2]刘彧,童清平,连娟,等. 乳腺癌弹性超声特征与分子生物学指标的相关性研究[J]. 东南国防医药,2015(2):116-118.
[3]Paplomata E, O Regan R. The PI3K/AKT/Mtor path-way in breast cancer: targets, trials and biomarkers[J]. Ther Adv Med Oncol, 2014,6(4):154-166.
[4]Kim JH, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs[J]. Am J Transl Res,2011,3(2) : 166-179.
[5]权恺,刘群,李萍,等.人参皂苷抗癌活性的最新研究进展[J]. 医学研究生学报,2015,28(4):427-431.
[6]黄社霄.人参、西洋参、三七药用探讨[J]. 中国中医药现代远程教育,2011,9(15):73-74.
[7]Zhang G, Liu A, Zhou Y, et al. Panax ginsengginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia [J]. J Ethnopharmacol, 2008,115 (3):441-448.
[8]Yu XT, Wang SP. Clinical ob servation on treatment for postoperative gastric cancer by ginsenoside Rg3 combined with chemotherapy [J]. Chin J Cancer Prev Treat,2010,17(10): 779-781.
[9]William CS, Chung WS, Sally KW, et al. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats [J]. Eur J Pharmacol, 2006,550(1-3): 173-179.
[10]Kim SE, Lee YH,Park HJ,et al. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21 WAF1 in human hepatoma SK-HEP-1 cells European [J]. Eur J Cancer, 1999,35(3):507-511.
[11]唐立,徐惠亮,郝双影.人参皂苷Rg3调控lncRNA-LINP1抑制胃癌细胞生长的作用机制[J]. 医学研究生学报,2020,33(11):1157-1160.
[12]董叶萍,周心怡,费思力,等.肝细胞癌细胞中差异表达环状RNA与microRNA-1相关的生物信息学分析[J]. 医学研究生学报,2020,33(3):246-250.
[13]童也,王宇翔,徐海栋.基于生物信息学方法的椎间盘退变miRNA芯片数据[J]. 医学研究生学报,2019,32(9):904-909.
[14]陈娟,刘传丽,陈艳思,等. IL-17A在卵巢癌中的表达水平及潜在机制的生物信息学分析[J]. 东南国防医药,2020,22(1):25-29.
[15]吴波,黄盛璟,邢婧,等.基于网络药理学的复方当归注射液治疗缺血性脑损伤作用机制分析[J]. 中国医院药学杂志, 2019,39(23):2384-2389.
[16]宋雪,司徒红林,林毅.林毅运用扶正祛邪法辩治复发转移性乳腺癌经验介绍[J]. 新中医,2017,49(6):177-178.
[17]朴丽花,蔡英兰,张默函,等.人参皂苷经PI3K/AKT通路诱导乳腺癌细胞凋亡[J]. 临床与实验病理学杂志,2013,29(9):946-948.
[18]王楠,廖莎,陈璐,等.人参皂苷Rb1对人乳腺癌MDA-MB-231细胞上皮-间质转化及ROR1表达的影响[J]. 中国药业,2020,29(21):25-28.
[19]陈军.人参皂苷对小鼠晚期乳腺癌模型的抑瘤作用[J]. 新乡医学院学报,2015, 32(12):1091-1094.
[20]董周威,王启威,张丽萍,等.利用生物信息技术分析喉癌的关键基因[J]. 医学研究杂志,2021,50(1):97-103.
[21]刘怀全,周芳芳,张玉佩,等.生物信息学在中西医结合基础研究汇总的应用前景[J]. 湖北民族大学学报(医学版),2020,37(2):49-52.
[22]Rahman MA, Toi M. Anti-angiogenic therapy in breast cancer[J]. Biomed Pharmacother, 2003, 57(10):463-470.
[23]Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.[J]. Cell, 1996, 86(3):353-364.
[24]Gabriela LM, NM Pía, Tatiana PL, et al. Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor Angiogenesis[J]. PLoS One, 2013, 8(2):e57572.
[25]赵伟博.基于非标记蛋白质组学不同淋巴结状态乳腺癌预后的候选血浆生物标志物筛选[D]. 无锡:江南大学,2019.
[26]胡雷,孙硕,毛露,等.尿激酶型纤溶酶原激活物系统作为乳腺癌预后生物标志物的展望[J]. 医学理论与实践,2020,33(1):30-32.
[27]毕薇薇,车轶群,李振家. 富含半胱氨酸的分泌型酸性蛋白与肿瘤的关系[J]. 国外医学,2005,26(8):551-552.
[28]朱璐.富含半胱氨酸的酸性分泌蛋白与恶性肿瘤[J]. 国际肿瘤学杂志,2010, 37(7):504-507.
[29]张婷婷,刘勇军,梁爱玲.微小RNA与乳腺癌[J]. 国际肿瘤学杂志,2014,41(1):37-40.

相似文献/References:

备注/Memo

备注/Memo:
基金项目:江苏省药学会药学服务专项科研项目(H202003)
更新日期/Last Update: 2022-06-21